Citrus Fit
Letter data
- Company
- Citrus Fit
- Recipient
- Citrus Fit | United States
- Issue date
- 2018-05-09
- Posted date
- Not available
- FDA office
- United States
- Subject
- Not available
- Product
- Not available
- CMS ID
- Not available
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Citrus Fit
May 09, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
Citrus Fit
United States
Issuing Office:
United States
Office of Human and Animal Food Operations West Division 3
4040 North Central Expressway, Suite 300
Dallas, Texas 75204
May 9, 2018
UPS OVERNIGHT
Raul Lopez Jr., Owner,
Citrus Fit Weight Loss and Detox Products, LLC
900E. Vermont Ave.
Apt. 19201
McAllen, TX 78503-1716
Dear Mr. Lopez
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter 2015-DAL-WL-01, dated October 15, 2014. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA surveillance and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. If you choose to reestablish or sale your operations, the Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Jessica E. Hensley
Director of Compliance Branch, OHAF-W3
Content current as of:
05/14/2018